Mylan CEO: Building for the long term

7:15 AM ET Thu, 11 Feb 2016

Heather Bresch, Mylan CEO, discusses her company's M&A strategy to continue to build out infrastructure, including the $7.2 billion acquisition of Swedish drugmaker Meda. Now we have critical mass around RX, GX, OTC and expansion into emerging markets, says Bresch. Also Bresch weighs in on tax inversions.